Flexible and sensitive method to functionally validate tumor-specific receptors via activation of NFAT.
about
T cell receptor (TCR) gene therapy to treat melanoma: lessons from clinical and preclinical studies.Locally-delivered T-cell-derived cellular vehicles efficiently track and deliver adenovirus delta24-RGD to infiltrating glioma.An Altered gp100 Peptide Ligand with Decreased Binding by TCR and CD8α Dissects T Cell Cytotoxicity from Production of Cytokines and Activation of NFAT.Lipid peroxidation causes endosomal antigen release for cross-presentation.T-cell synapse formation depends on antigen recognition but not CD3 interaction: studies with TCR:ζ, a candidate transgene for TCR gene therapy.
P2860
Flexible and sensitive method to functionally validate tumor-specific receptors via activation of NFAT.
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Flexible and sensitive method ...... eptors via activation of NFAT.
@ast
Flexible and sensitive method ...... eptors via activation of NFAT.
@en
type
label
Flexible and sensitive method ...... eptors via activation of NFAT.
@ast
Flexible and sensitive method ...... eptors via activation of NFAT.
@en
prefLabel
Flexible and sensitive method ...... eptors via activation of NFAT.
@ast
Flexible and sensitive method ...... eptors via activation of NFAT.
@en
P2093
P1476
Flexible and sensitive method ...... eptors via activation of NFAT.
@en
P2093
Birgit Lankiewicz
Jan Willem Gratama
Reinder L H Bolhuis
Reno Debets
P356
10.1016/S0022-1759(03)00067-X
P50
P577
2003-09-01T00:00:00Z